Vertex

(Reuters) - Vertex Pharmaceuticals Inc. sued the U.S. Department of Health and Human Services on Monday seeking a court declaration that its fertility support program for patients prescribed its gene-editing treatment Kasgevi does not…

(Reuters) -Vertex Pharmaceuticals will buy Alpine Immune Sciences (NASDAQ:) for about $4.9 billion in cash, gaining access to the biotech firm's treatment for an autoimmune disease of the kidney, the companies said on Wednesday. The deal…

Vertex Pharmaceuticals (NASDAQ:), a leading biotechnology firm, has been under the Wall Street microscope as analysts weigh in on the company's prospects, particularly in light of its expanding pipeline beyond its stronghold…

iQoncept Buoyed by booming diabetes drug sales, Eli Lilly (New York Stock Exchange: LLY) was the best performer in big pharma or biotech in the first half of 2023, returning dazzling 28%. Coming in at number two, Vertex Pharmaceuticals…

Vertex Labs (https://vertexlabs.uk/), the brains behind the Caduceus metaverse protocol, the Vertex network and 3D metaverse platform, LightCycle, has acquired London-based digital arts studio Digimental Studio (Digimental), the driving…